A distinct subtype, triple-negative breast cancer (TNBC), does not express the estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER−2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.